KIMBERLY DOYLE: Open Payments
NPI 1396160297 · OAK BROOK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,946 in 193 payments from 21 companies in 2025. Trend: 2023 $6,969 · 2024 $7,128 · 2025 $8,946
Food & beverage: $5,595Speaker / faculty: $3,300Travel & lodging: $31Education: $20
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 34 | $4,028 |
| ABBVIE INC. | 31 | $1,189 |
| Novo Nordisk Inc | 22 | $772 |
| Madrigal Pharmaceuticals | 5 | $441 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $285 |
| Currax Pharmaceuticals LLC | 18 | $238 |
| RECORDATI_RARE_DISEASES_INC. | 8 | $236 |
| PFIZER INC. | 12 | $236 |
| Aimmune Therapeutics, Inc. | 9 | $202 |
| Esperion Therapeutics, Inc. | 4 | $201 |
Products named: ZEPBOUND, VRAYLAR, Wegovy, REZDIFFRA, Kerendia, ISTURISA, NURTEC ODT, MOUNJARO.
Industry payments across IL — which companies pay providers there.
